Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects

British Journal of Clinical Pharmacology

Volumn 58, Issue 4, 2004, Pages 345-351

  Cardot, J M ^a,c   Chaumont, C ^b   Dubray, C ^c   Costantini, D ^b   Aiache, J M ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b BioAlliance Pharma   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Bioadhesive tablet; Miconazole; Pharmacokinetics

Indexed keywords

LAURIAD; MICONAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG SALIVA LEVEL; FEMALE; GEL; HUMAN; HUMAN EXPERIMENT; MALE; MOUTH CAVITY; NORMAL HUMAN; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLOW RELEASE FORMULATION; THRUSH;

ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; GELS; HUMANS; MALE; MICONAZOLE; PLASMA; SALIVA; TABLETS;

EID: 4744370804     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02154.x     Document Type: Article

References (18)

1. Appleton SS. Candidiasis: pathogenesis, clinical characteristics and treatment. J Calif Dent Assoc 2000; 28: 942-8.
2. Epstein AN, Stevenson Moore P. Periodontal disease and periodontal management in patients with cancer. Oral Oncol 2001; 37: 613-16.
3. Powderly WG, Gallant JE, Ghannoum MA, Mayer KH, Navarro EE, Perfect JR. Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy. AIDS Res Hum Retroviruses 1999; 15: 1619-23.
4. Vaszquez JA. Options for management of muccosal candidiasis in patients with AIDS and HIV infection. Pharmacotherapy 1999; 18: 554-64.
5. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE. Practice guidelines for the treatment of candisosis. Clin Infect Dis 2000; 30: 662-78.
6. Ellopola AN, Samaranayake LP, Lee MT. Miconazole agent in oral candidosis: an overview. Dent Update 2000; 27: 165-70.
7. Lesse AJ. Antifungal agents. In Essentials of Pharmacology, eds Smith CM, Reynard A. Philadelphia, W.B. Saunders 1995; 404-11.
8. Hoesley C, Dismukes WE. Overview of oral azole drugs as systemic anti-fungal therapy. Semin Resp Crit Care Medl 1997; 18:301-9.
9. Meis JF, Verweij PE. Current management of fungal infections. Drugs 2001; 61: 13-25.
10. Samaranayake LP, Holmstrup P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989; 18: 554-64.
11. Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS. Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs 1975; 9: 406-23.
12. Aïache J-M, Costantini D, Chaumont C. 2003 Patent WO 03/009800, Sustained release therapeutic bioadhesive system.
13. Compendium Suisse (Swiss Medicinal Compendium). Switzerland, Documed AG, 2003.
14. Vidal, le dictionnaire (French Medicinal Dictionary). Issy les Moulineaux, France, Vidal. 2003.
15. Chaumont C, Cardot J-M, Dubray C, Costantini D, Aiache J-M. Safety, acceptability and adhesion of novel bioadhesive slow release tablet of miconazole in a phase I study. J Mycol Med 2003; 13: 13-18.
16. Bouckaert S, Schautteet H, Lefebvre R, Remon J, Van Clooster R. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel. Eur J Clin Pharmacol 1992; 43: 137-40.
17. Wagner JG. Fundamentals of Clinical Pharmacokinetics, first edition 1975. Washington DC, USA, American Pharmaceutical Association, 1987; 174-5.
18. Cardot J-M, Jaouen A, Godbillon J. PKC, a new pharmacokinetic software using SAS. Eur J Pharm Biopharm 1997; 43: 197-9.